➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Colorcon
Moodys
Medtronic
AstraZeneca

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-07-22 109 Notice of Service Buckton on Infringement of U.S. Patent 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 11 April 2019 1:19-cv-00678 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-08-21 111 Notice of Service Graham Buckton on Validity of U.S. Patent 9,669,008; 9,808,442; 10,039,745; and 10,154,987; (2) Expert Report… 11 April 2019 1:19-cv-00678 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-10-02 114 Notice of Service Buckton on Infringement of U.S. Patent 9,669,008; 9,808,442; 10,039,745; and 10,154,987 filed by Silvergate… 11 April 2019 1:19-cv-00678 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-10-29 117 Redacted Document the ’745 Patent U.S. Patent No. 10,039,745 the ’987 Patent U.S. Patent No. 10,154,987 Original…Application the ’008 Patent U.S. Patent No. 9,669,008 the ’442 Patent U.S. Patent No. 9,808,442 the…the ’868 patent U.S. Patent No. 10,772,868 New Patents The ’482 and ’868 patents, collectively…infringement of the ’008 Patent, the ’442 Patent, the ’745 Patent, and the ’987 Patent (collectively, the …Original Patents The ’008, ’442, ’745, and ’987 patents, collectively the ’482 patent U.S. Patent External link to document
2020-10-30 119 accord D.I. 353 at 182:10-183:4). C. Prosecution of the ’405 Patent 1. …consolidated patent infringement action arising under the Drug Price Competition and Patent Term Restoration…Hatch-Waxman Act. United States Patent No. 9,375,405 (the “’405 patent”) is assigned to Plaintiff Amgen…BACKGROUND A. The ’405 Patent The ’405 patent, entitled “Rapid Dissolution Formulation… was issued by the United States Patent and Trademark Office (“Patent Office”) on June 28, 2016. (D. External link to document
2019-04-11 4 Patent/Trademark Report to Commissioner Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,669,008 B1 ;9,808,442 B2 ;10,039,745 B2 ;… 11 April 2019 1:19-cv-00678 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
Colorcon
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.